Pediatrix Medical (MD) Equity Average (2010 - 2026)

Pediatrix Medical (MD) has 17 years of Equity Average data on file, last reported at $872.2 million in Q1 2026.

• Quarterly Equity Average rose 12.25% year-over-year to $872.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $872.2 million (up 12.25% YoY) and the FY2025 annual result came in at $815.4 million, up 1.04% from the prior year.
• Equity Average declined to $872.2 million in Q1 2026 per MD's latest filing, from $878.3 million in the prior quarter.
• Across five years, Equity Average topped out at $955.2 million in Q3 2023 and bottomed at $719.5 million in Q3 2024.
• The 5-year median for Equity Average is $862.2 million (2025), against an average of $851.1 million.
• The widest annual swing landed in 2024, when Equity Average retreated 24.68%; it then grew 19.84% in 2025.
• Tracing MD's Equity Average over 5 years: stood at $875.1 million in 2022, then climbed by 3.81% to $908.5 million in 2023, then slipped by 17.59% to $748.7 million in 2024, then rose by 17.3% to $878.3 million in 2025, then dropped by 0.69% to $872.2 million in 2026.
• Per Business Quant, the three latest MD Equity Average figures stand at $872.2 million (Q1 2026), $878.3 million (Q4 2025), and $862.2 million (Q3 2025).

Peer Comparison